Gillessen, S, Gallardo, E, Choudhury, A, Saad, F, Soares, A, Loriot, Y, McDermott, R, Rodriguez-Vida, A, Velho, PI, Nolè, F, Cruz, F, Roumeguere, T, Daugaard, G, Yamamura, R, Bompas, E, Maroto, P, Veiga, FG, Skoneczna, I, da Trindade, KM, Carcano, FM, Lecouvet, F, Coens, C, Poncet, C, Fournier, B, Tombal, B. Final overall survival results from EORTC 1333/PEACE-3 trial of enzalutamide plus radium-223 in metastatic castration-resistant prostate cancer. ANNALS OF ONCOLOGY. 2026; 37(5)DOI:10.1016/j.annonc.2026.02.009. PMID:41763609. IF:65.400(Q1/1D).

Yaringaño, J, Mirallas, O, Navarro, V, Gómez-Puerto, D, Velilla, G, Vaz, MA, Gorria, T, Martínez-Monino, A, Hernández, A, Aguado, M, Di Muzio, A, Valbuena, DL, Ruiz-Pace, F, González, M, Martínez-García, M, Villacampa, G, Balaña, C, Carles, J, Dienstmann, R, Pineda, E, Sepúlveda, JM, Vieito, M. Progression-Free Survival 2 as a Potential Surrogate for Overall Survival in Glioblastoma: Insights From a Spanish Multicentric Cohort. Cancer Medicine. 2026; 15(4)DOI:10.1002/cam4.71825. PMID:42002922. IF:3.100(Q2/5D).

Gámez-Pozo, A, Trilla-Fuertes, L, Becerril-Gómez, F, Lalanda-Delgado, P, Soriano, V, Goldaraz, FG, Lecumberri, MJ, de la Borbolla, MR, Majem, M, Pérez-Ruiz, E, González-Cao, M, Oramas, J, López-Vacas, R, Magdaleno, A, Fra, J, Martín-Carnicero, A, Corral, M, Puértolas, T, Ramos-Ruiz, R, Espinosa, E, Vara, JAF. Immune classification of advanced melanoma identifies non-responders to anti-PD1 therapy. CANCER IMMUNOLOGY IMMUNOTHERAPY. 2026; 75(5)DOI:10.1007/s00262-026-04392-1. PMID:42047827. IF:5.100(Q1/3D).

Herrera, IC, Cols, LC, Pijuan-Andujar, L, Cajo, SA, Montalvan, RG, Calvente, MG, Luque, GA, Gallardo, A, Jaramillo, JFC. Impact of Cell-Free TNA Fraction on Analytical Success in Liquid Biopsy for Lung Adenocarcinoma: Experience from a Tertiary Hospital. LABORATORY INVESTIGATION. 2026; 106(3)DOI:10.1016/j.labinv.2025.105990. PMID:. IF:4.200(Q1/1D).